drugset / Trial / NCT03517761

Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries

NCT03517761

Recruiting 80 enrolled Regenexx, LLC
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of using anterior approach through the posterior oropharynx for treating alar and transverse ligament injuries with bone marrow concentrate for patients with craniocervical junction (CCJ) instability.

Timeline

Start
2018-03-23
Primary completion
2030-12
Completion
2030-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bone Marrow Concentrate Cell therapy Other

Indications